Physician profile
Kyle A Caswell
NPI 1508057324
$3,496.84
in general payments reported to CMS, 2019-2025
13 companies · $702 in 2025
The $702 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,111 · 2020: $25.78 · 2021: $1,350 · 2022: $107 · 2023: $102 · 2024: $98.91 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $499 · Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $499.46 |
| Food and Beverage | $403.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $2,353.96 | 2019-2022 | |
| Stryker Corporation | $722.05 | 2024-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Amgen INC. | $133.24 | 2021-2025 | Evenity, Prolia |
| Smith+Nephew, INC. | $63.22 | 2021-2023 | Pico 7 |
| Bioventus LLC | $50.28 | 2024 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $30.46 | 2021 | |
| Sanara Medtech INC. | $28.58 | 2022 | |
| Horizon Therapeutics Plc | $25.78 | 2020 | |
| Vericel Corporation | $22.44 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.77 | 2023 | Iovera, Zilretta, Exparel |
| Zyla Life Sciences, INC. | $16.84 | 2019 | |
| Fidia Pharma USA INC. | $16.24 | 2021 | |
| Abbvie INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Caswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.